Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.1M |
| 2 |
3M
MMM
|
+$9.06M |
| 3 |
Nike
NKE
|
+$6.91M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$5.3M |
| 5 |
American Tower
AMT
|
+$4.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$55.8M |
| 2 |
Broadridge
BR
|
+$20.6M |
| 3 |
Bankunited
BKU
|
+$15.2M |
| 4 |
Cinemark Holdings
CNK
|
+$14.8M |
| 5 |
Dover
DOV
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.18% |
| 2 | Miscellaneous | 4.54% |
| 3 | Financials | 2.4% |
| 4 | Technology | 1.69% |
| 5 | Consumer Staples | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $3.24B | 83.09% |
27,070,567
-499,233
| -2% | -$55.8M |
2013 Q2
12 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$847B
| $50.5M | 1.29% |
240,103
+115,575
| +93% | +$24.1M |
2013 Q2
12 quarters
|
|
3
Wells Fargo
WFC
$252B
| $20.5M | 0.52% |
433,025
-56,882
| -12% | -$2.77M |
2013 Q2
12 quarters
|
|
4
Chubb
CB
$139B
| $18.6M | 0.48% |
142,237
-18,872
| -12% | -$2.33M |
2013 Q2
12 quarters
|
|
5
State Street Energy Select Sector SPDR ETF
XLE
$40.6B
| $18.3M | 0.47% |
535,974
-868
| -0.2% | -$28.6K |
2015 Q4
2 quarters
|
|
6
PepsiCo
PEP
$193B
| $17.7M | 0.45% |
167,226
-22,185
| -12% | -$2.29M |
2013 Q2
12 quarters
|
|
7
Apple
AAPL
$4.98T
| $15.7M | 0.4% |
655,128
-57,220
| -8% | -$1.42M |
2013 Q2
12 quarters
|
|
8
Aflac
AFL
$61.5B
| $15.5M | 0.4% |
430,932
-62,532
| -13% | -$2.14M |
2013 Q4
10 quarters
|
|
9
Verizon
VZ
$189B
| $14.5M | 0.37% |
259,336
-33,301
| -11% | -$1.73M |
2013 Q2
12 quarters
|
|
10
Procter & Gamble
PG
$383B
| $13.4M | 0.34% |
158,242
-19,502
| -11% | -$1.6M |
2013 Q2
12 quarters
|
|
11
Sherwin-Williams
SHW
$83.1B
| $12.7M | 0.33% |
129,669
-18,675
| -13% | -$1.82M |
2015 Q2
4 quarters
|
|
12
NextEra Energy
NEE
$182B
| $12.7M | 0.32% |
388,348
-46,020
| -11% | -$1.38M |
2013 Q2
12 quarters
|
|
13
iShares S&P 500 Growth ETF
IVW
$72.1B
| $12.4M | 0.32% |
425,008
+103,288
| +32% | +$3M |
2013 Q2
12 quarters
|
|
14
iShares S&P 500 Value ETF
IVE
$49.9B
| $12.4M | 0.32% |
133,231
+33,645
| +34% | +$3.08M |
2013 Q2
12 quarters
|
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $12.3M | 0.31% |
124,640
-112,000
| -47% | -$11.6M |
2013 Q2
12 quarters
|
|
16
Gilead Sciences
GILD
$207B
| $12M | 0.31% |
143,612
-24,683
| -15% | -$2.19M |
2015 Q2
4 quarters
|
|
17
DELISTED
Ansys
ANSS
| $11.7M | 0.3% |
128,482
-12,695
| -9% | -$1.12M |
2016 Q1
1 quarter
|
|
18
Merck
MRK
$362B
| $11.1M | 0.28% |
201,609
-30,872
| -13% | -$1.64M |
2013 Q2
12 quarters
|
|
19
Lockheed Martin
LMT
$131B
| $11M | 0.28% |
44,453
-5,435
| -11% | -$1.28M |
2016 Q1
1 quarter
|
|
20
Honeywell
HON
$69.7B
| $11M | 0.28% |
105,072
-15,118
| -13% | -$1.55M |
2013 Q2
12 quarters
|
|
21
Alphabet (Google) Class C
GOOG
$3.49T
| $10.8M | 0.28% |
311,620
-22,300
| -7% | -$801K |
2013 Q2
12 quarters
|
|
22
iShares MSCI EAFE ETF
EFA
$75.6B
| $10.7M | 0.27% |
191,005
+5,137
| +3% | +$296K |
2013 Q2
12 quarters
|
|
|
23
3M
MMM
$95.5B
| $10.1M | 0.26% |
69,137
+64,225
| +1,308% | +$9.06M |
2013 Q2
12 quarters
|
|
24
US Bancorp
USB
$92.6B
| $10M | 0.26% |
248,919
-27,555
| -10% | -$1.15M |
2015 Q4
2 quarters
|
|
|
25
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $9.9M | 0.25% |
332,055
+180,665
| +119% | +$5.3M |
2013 Q2
12 quarters
|
|
Similar funds
Greenleaf Trust's Q2 2016 Portfolio in Review
As of Q2 2016, Greenleaf Trust held 182 positions worth $3.9B, up 6.2% from $3.68B the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Greenleaf Trust withdrew a net $126M in Q2 2016, closing 10 positions and reducing 92 holdings. Its most notable exit was Bankunited, an estimated $15.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 83% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Greenleaf Trust opened a new position in Nike worth $6.69M.
- Greenleaf Trust's largest Q2 2016 buy was Nike: 121,208 shares worth $6.69M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q2 2016, an estimated $24.1M increase.
- Greenleaf Trust's biggest Q2 2016 reduction was Stryker, cutting an estimated $55.8M.
- Greenleaf Trust fully exited Bankunited in Q2 2016, selling an estimated $15.2M.
- Greenleaf Trust's ten largest holdings make up 88% of its $3.9B portfolio in Q2 2016.
- Greenleaf Trust opened 20 new positions and closed 10 in Q2 2016.
- Greenleaf Trust's portfolio value rose 6.2% quarter-over-quarter to $3.9B.
Based on Greenleaf Trust's 13F filing for Q2 2016, filed 28 Jul 2016.